Chronic degenerative diseases and their prevention

In the context of modern preventive medicine, targeted nutritional support is a practical tool for modulating the main risk factors underlying chronic degenerative diseases. In particular, low-grade chronic inflammation, oxidative stress, immune dysfunction, and micronutrient deficiencies are now recognized as key factors in the loss of physiological balance.

A rational and sustainable approach involves the synergistic integration of nutrients and bioactive compounds with proven biological activity. The combined use of the following fits into this context:

• MOLTITUDO® LUNAE → modulation of inflammation and the tissue microenvironment
• MOLTITUDO® FERROSA → hematological, energy, and immune support

PRODUCTS_ARTICLE

MOLTITUDO® LUNAE: inflammation control and systemic support

Chronic inflammation is a central driver in the development of cardiovascular, metabolic, joint, and intestinal diseases. LUNAE acts through three key components:

1. Bromelain

Bromelain, a proteolytic enzyme derived from Ananas comosus, has been shown to have:

• anti-edematous and anti-inflammatory activity
• improved lymphatic drainage
• positive effects on tissue permeability

Evidence: clinical and preclinical studies show a reduction in edema and inflammatory markers (Secor et al., 2005; Pavan et al., 2012).

2. Boswellia serrata

Boswellic acids inhibit 5-lipoxygenase (5-LOX), reducing the synthesis of pro-inflammatory leukotrienes.

Clinical evidence:

• improved pain and joint function
• reduced intestinal inflammation

(Rahman et al., 2020; Sengupta et al., 2008)

3. Tetrahydrocurcuminoids

Active metabolites of curcumin with high bioavailability:

• activate the Nrf2/HO-1 pathway
• reduce oxidative stress and inflammation

(Zhang et al., 2021)

Clinical rationale

LUNAE supports:

• systemic inflammatory balance
• joint and intestinal function
• microcirculation and drainage

Preventive use: 1 tablet per day

MOLTITUDO® FERROSA: cellular energy and immune function

Iron is essential for:

• hemoglobin synthesis
• oxygen transport
• mitochondrial energy metabolism

Even a subclinical deficiency may result in:

• fatigue
• reduced cognitive performance
• impaired immune response

Liposomal technology

Liposomal iron:

• improves bioavailability
• reduces gastrointestinal side effects
• protects the intestinal mucosa

(Sucrosomial® iron studies – Cancelo-Hidalgo et al., 2013)

Micronutrient synergy

• Vitamin C → increases iron absorption
• Vitamins B (B6, B12, folates) → erythropoiesis
• Vitamin D, zinc, selenium → immunomodulation
• Vitamin K2 → vascular support

Scientific evidence

• Iron contributes to cognitive and immune function (EFSA, 2015)
• Vitamin D and zinc modulate the immune response (Gombart et al., 2020)
• B vitamins reduce homocysteine, a cardiovascular risk factor

Clinical rationale

FERROSA supports:

• energy and vitality
• tissue oxygenation
• immune system

Preventive indication: 1 capsule daily

LUNAE + FERROSA synergy in prevention

The combination of the two supplements acts on multiple levels:

This integrated approach reflects a physiological view of prevention: not acting on the symptom, but on the biological mechanisms underlying the imbalance.

Recommended use

• MOLTITUDO® LUNAE → 1 tablet daily
• MOLTITUDO® FERROSA → 1 capsule daily

Preferably taken with meals, in 2–3 month cycles, repeatable throughout the year.

Safety and clinical considerations

• Supplements do not replace a balanced diet
• Consult a doctor in case of medical conditions or pharmacological treatments
• Avoid overdoses, especially of iron and vitamin D

Conclusions

Effective prevention is based on targeted and sustainable interventions over time. The combined use of MOLTITUDO® LUNAE and MOLTITUDO® FERROSA represents a rational strategy to:

• modulate inflammation and oxidative stress
• support energy and immune function
• maintain the body's physiological balance

An approach that integrates nutrition, physiology, and molecular biology, in line with the latest scientific evidence.

Essential bibliographic references

• Zhang Q. et al. (2021). Activation of Nrf2/HO-1 signaling. Journal of Advanced Research
• Pavan R. et al. (2012). Bromelain: pharmacological effects. Biotechnology Research International
• Sengupta K. et al. (2008). Boswellia in osteoarthritis. Arthritis Research & Therapy
• Cancelo-Hidalgo MJ. et al. (2013). Tolerability of oral iron formulations. Curr Med Res Opin
• Gombart AF. et al. (2020). Micronutrients and immune function. Nutrients
• EFSA (2015). Iron and immune function claims

PLEASE NOTE: The information provided in the product sheets on this website is for informational and educational purposes only and does not constitute medical advice. The published content is not intended to replace your relationship with your doctor or any medical advice, diagnosis, or prescription. The information provided describes the ingredients and characteristics of food supplements, which are intended to support the body's balance and well-being as part of a healthy lifestyle. Food supplements are not medicines and must not be used to prevent, diagnose, treat, or alleviate diseases or medical conditions.